Ex-Pharma Exec Admits Insider Trading On Cancer Drug Info
A former executive at a California pharmaceutical company pled guilty in Massachusetts federal court on Thursday to criminal charges that he reaped $1.16 million from stock trades on nonpublic knowledge that...To view the full article, register now.
Already a subscriber? Click here to view full article